Hits:

Title of Paper:Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study

Journal:Signal Transduction and Targeted Therapy

Discipline:Medicine

Volume:10

Issue:1

Page Number:45

Impact Factor:40.8

Translation or Not:No

Date of Publication:2025-01

Included Journals:SCI

Release Time:2025-02-02